Copeland Capital Management LLC increased its position in U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 8.9% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 888,735 shares of the company's stock after acquiring an additional 72,463 shares during the quarter. U.S. Physical Therapy comprises about 1.4% of Copeland Capital Management LLC's investment portfolio, making the stock its 19th biggest position. Copeland Capital Management LLC owned about 5.85% of U.S. Physical Therapy worth $69,499,000 at the end of the most recent reporting period.
Other institutional investors have also recently bought and sold shares of the company. GAMMA Investing LLC raised its holdings in U.S. Physical Therapy by 27,856.8% in the 1st quarter. GAMMA Investing LLC now owns 12,301 shares of the company's stock worth $890,000 after acquiring an additional 12,257 shares during the period. Park Avenue Securities LLC bought a new position in U.S. Physical Therapy in the 2nd quarter worth $481,000. Sowell Financial Services LLC bought a new position in U.S. Physical Therapy in the 2nd quarter worth $204,000. Comerica Bank raised its holdings in U.S. Physical Therapy by 3.0% in the 1st quarter. Comerica Bank now owns 8,181 shares of the company's stock worth $592,000 after acquiring an additional 237 shares during the period. Finally, Principal Financial Group Inc. grew its position in U.S. Physical Therapy by 2.3% in the 1st quarter. Principal Financial Group Inc. now owns 84,964 shares of the company's stock worth $6,148,000 after purchasing an additional 1,873 shares during the last quarter.
Insider Activity
In related news, COO Eric Joseph Williams sold 1,000 shares of U.S. Physical Therapy stock in a transaction dated Friday, September 5th. The shares were sold at an average price of $85.25, for a total transaction of $85,250.00. Following the completion of the transaction, the chief operating officer directly owned 25,331 shares of the company's stock, valued at $2,159,467.75. This trade represents a 3.80% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Christopher J. Reading sold 2,000 shares of U.S. Physical Therapy stock in a transaction dated Thursday, September 4th. The shares were sold at an average price of $83.53, for a total transaction of $167,060.00. Following the transaction, the chief executive officer directly owned 114,088 shares of the company's stock, valued at $9,529,770.64. This represents a 1.72% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 6,853 shares of company stock worth $581,406 over the last ninety days. Corporate insiders own 2.00% of the company's stock.
Analyst Upgrades and Downgrades
Several research firms have issued reports on USPH. JPMorgan Chase & Co. began coverage on shares of U.S. Physical Therapy in a research report on Thursday, September 18th. They issued an "overweight" rating and a $110.00 price target on the stock. Zacks Research upgraded shares of U.S. Physical Therapy to a "hold" rating in a research report on Friday, August 8th. Wall Street Zen lowered shares of U.S. Physical Therapy from a "buy" rating to a "hold" rating in a research report on Sunday, September 21st. Finally, Barrington Research raised their price target on shares of U.S. Physical Therapy from $98.00 to $103.00 and gave the stock an "outperform" rating in a research report on Friday, August 8th. One investment analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $110.25.
Read Our Latest Stock Report on USPH
U.S. Physical Therapy Price Performance
Shares of U.S. Physical Therapy stock opened at $87.34 on Friday. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.18 and a current ratio of 1.18. The firm's 50-day simple moving average is $81.78 and its 200-day simple moving average is $76.73. U.S. Physical Therapy, Inc. has a twelve month low of $62.77 and a twelve month high of $101.19. The firm has a market cap of $1.33 billion, a P/E ratio of 38.14, a price-to-earnings-growth ratio of 4.31 and a beta of 1.48.
U.S. Physical Therapy (NYSE:USPH - Get Free Report) last issued its earnings results on Wednesday, August 6th. The company reported $0.81 earnings per share for the quarter, beating the consensus estimate of $0.71 by $0.10. U.S. Physical Therapy had a net margin of 5.05% and a return on equity of 8.78%. The business had revenue of $197.34 million for the quarter, compared to analyst estimates of $190.24 million. During the same period in the previous year, the business earned $0.73 EPS. The firm's revenue was up 18.0% on a year-over-year basis. As a group, research analysts expect that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current fiscal year.
U.S. Physical Therapy Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Friday, September 12th. Investors of record on Friday, August 22nd were issued a dividend of $0.45 per share. This represents a $1.80 annualized dividend and a yield of 2.1%. The ex-dividend date of this dividend was Friday, August 22nd. U.S. Physical Therapy's dividend payout ratio (DPR) is currently 78.60%.
About U.S. Physical Therapy
(
Free Report)
U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
See Also
Want to see what other hedge funds are holding USPH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider U.S. Physical Therapy, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and U.S. Physical Therapy wasn't on the list.
While U.S. Physical Therapy currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report